Community lists
큐레이션 · 헬스케어

Lab tools & diagnostics

InspectStocks 제공Published 2026년 10월 14일20 companies0 followers

Instruments, supplies and testing services for labs, drugmakers and doctors.

AI 모델의 도움으로 묶고 편집자가 검토했습니다. 각 기업 아래의 한 줄이 이 기업이 여기 있는 이유를 설명합니다.

주가는 2026년 11월 11일 종가이며, IEX 거래소 피드 기준입니다.

Grade mix

A 8B 8C 2D 1F 1

Revenue growing

19 of 20

Free cash flow growing

9 of 20

Median price move, 1 year

+22.0%

  • TMOTHERMO FISHER SCIENTIFIC INC.

    Diagnostics and researchMarket cap US$265.9BP/E 37.85

    US$717.62+22.5%1Y

    Since added +8.2%

    A+
    성장과 현금
    강하게 성장 중
    Business trend
    가속
    Business quality
    우수
    Getting better
    개선 중

    Revenue

    US$47.4B+8.3%

    Profit

    US$7.1B+7.6%

    Free cash flow

    US$7.6B+24.3%
    Why it is here: Sells lab instruments, reagents and services to researchers and drug makers
  • DHRDANAHER CORPORATION

    Diagnostics and researchMarket cap US$165.5BP/E 38.51

    US$235.31+8.0%1Y

    Since added +5.4%

    B+
    성장과 현금
    강하게 성장 중
    Business trend
    가속
    Business quality
    우수
    Getting better
    개선 중

    Revenue

    US$25.6B+5.5%

    Profit

    US$4.3B+23.6%

    Free cash flow

    US$5.7B+14.2%
    Why it is here: Sells research instruments, supplies and services
  • AAGILENT TECHNOLOGIES, INC.

    Diagnostics and researchMarket cap US$49.9BP/E 34.89

    US$176.91+17.6%1Y

    Since added +3.1%

    B+
    성장과 현금
    강하게 성장 중
    Business trend
    가속
    Business quality
    우수
    Getting better
    개선 중

    Revenue

    US$7.4B+8.6%

    Profit

    US$1.4B+18.0%

    Free cash flow

    US$1.3B+16.5%
    Why it is here: Sells lab instruments, consumables and software to labs and drug makers
  • WATWaters Corporation

    Diagnostics and researchMarket cap US$46.3BP/E 202.08

    US$470.84+21.5%1Y

    Since added +9.7%

    D
    성장과 현금
    성장 중
    Business trend
    둔화
    Business quality
    혼조
    Getting better
    혼조

    Revenue

    US$5.6B+84.2%

    Profit

    US$98.6M-84.8%

    Free cash flow

    US$290.8M-51.7%
    Why it is here: Sells liquid chromatography and mass spectrometry instruments and consumables
  • MTDMettler-Toledo International Inc.

    Diagnostics and researchMarket cap US$34.8BP/E 37.95

    US$1,749.30+20.8%1Y

    Since added +9.4%

    B+
    성장과 현금
    강하게 성장 중
    Business trend
    안정
    Business quality
    우수
    Getting better
    개선 중

    Revenue

    US$4.2B+6.5%

    Profit

    US$934.1M+11.8%

    Free cash flow

    US$870.6M-2.1%
    Why it is here: Makes precision laboratory instruments and weighing equipment
  • ILMNIllumina, Inc.

    Diagnostics and researchMarket cap US$32.2BP/E 36.64

    US$212.86+74.5%1Y

    Since added -21.5%

    A+
    성장과 현금
    강하게 성장 중
    Business trend
    안정
    Business quality
    우수
    Getting better
    크게 개선 중

    Revenue

    US$4.5B+5.8%

    Profit

    US$895M+27.5%

    Free cash flow

    US$1.1B+5.7%
    Why it is here: Sells DNA sequencing instruments and reagents
  • IDXXIDEXX LABORATORIES INC /DE

    Diagnostics and researchMarket cap US$55.4BP/E 47.37

    US$703.00-1.5%1Y

    Since added +35.2%

    A+
    성장과 현금
    강하게 성장 중
    Business trend
    안정
    Business quality
    우수
    Getting better
    크게 개선 중

    Revenue

    US$4.7B+11.9%

    Profit

    US$1.2B+15.1%

    Free cash flow

    US$1.3B+35.3%
    Why it is here: Sells veterinary diagnostic tests and instruments
  • DGXQuest Diagnostics Inc

    Diagnostics and researchMarket cap US$28.5BP/E 25.77

    US$258.72+40.8%1Y

    Since added +12.2%

    A
    성장과 현금
    강하게 성장 중
    Business trend
    안정
    Business quality
    양호
    Getting better
    개선 중

    Revenue

    US$11.8B+9.1%

    Profit

    US$1.1B+16.5%

    Free cash flow

    US$1.4B-1.3%
    Why it is here: Provides diagnostic testing and clinical lab services
  • LHLABCORP HOLDINGS INC.

    Diagnostics and researchMarket cap US$30.2BP/E 30.53

    US$372.18+41.3%1Y

    Since added +18.7%

    A
    성장과 현금
    강하게 성장 중
    Business trend
    안정
    Business quality
    혼조
    Getting better
    크게 개선 중

    Revenue

    US$14.6B+6.0%

    Profit

    US$1B+17.4%

    Free cash flow

    US$1.3B-6.8%
    Why it is here: Provides diagnostic tests and clinical lab services
  • RVTYREVVITY, INC

    Diagnostics and researchMarket cap US$17.7BP/E 70.32

    US$158.22+68.5%1Y

    Since added +2.0%

    A
    성장과 현금
    강하게 성장 중
    Business trend
    안정
    Business quality
    혼조
    Getting better
    개선 중

    Revenue

    US$2.9B+4.6%

    Profit

    US$253.2M+6.6%

    Free cash flow

    US$590.5M+18.7%
    Why it is here: Sells lab instruments, reagents and diagnostics tools to research and drug makers
  • IQVIQVIA HOLDINGS INC.

    Diagnostics and researchMarket cap US$45.2BP/E 33.38

    US$274.37+24.2%1Y

    Since added +5.2%

    A
    성장과 현금
    강하게 성장 중
    Business trend
    안정
    Business quality
    혼조
    Getting better
    개선 중

    Revenue

    US$17.3B+8.8%

    Profit

    US$1.4B+8.7%

    Free cash flow

    US$2.1B-6.0%
    Why it is here: Runs clinical trials and sells healthcare data to drugmakers
  • NTRANATERA, INC.

    Diagnostics and researchMarket cap US$46.4BP/E 없음 (영업손실)

    US$319.77+52.6%1Y

    Since added -19.2%

    B-
    성장과 현금
    강하게 성장 중
    Business trend
    안정
    Business quality
    취약
    Getting better
    혼조

    Revenue

    US$2.9B+37.4%

    Profit

    -US$164.7M+46.7%

    Free cash flow

    US$52.5M-50.5%
    Why it is here: Provides genetic and cell-free DNA diagnostic tests
  • TECHBIO-TECHNE Corp

    BiotechnologyMarket cap US$11.4BP/E 66.77

    US$72.78+19.2%1Y

    Since added +0.4%

    A+
    성장과 현금
    강하게 성장 중
    Business trend
    가속
    Business quality
    우수
    Getting better
    크게 개선 중

    Revenue

    US$1.2B+0.9%

    Profit

    US$172M+120.5%

    Free cash flow

    US$308.2M+37.6%
    Why it is here: Sells proteins, antibodies and diagnostic reagents to researchers
  • BRKRBRUKER CORPORATION

    Medical devicesMarket cap US$9.5BP/E 없음 (영업손실)

    US$62.41+47.5%1Y

    Since added +11.0%

    B
    성장과 현금
    강하게 성장 중
    Business trend
    둔화
    Business quality
    혼조
    Getting better
    혼조

    Revenue

    US$3.5B+2.2%

    Profit

    -US$123.4M-490.4%

    Free cash flow

    US$244.7M+2,408.5%
    Why it is here: Makes scientific instruments for microscopy, spectroscopy and magnetic resonance research
  • RGENREPLIGEN CORP

    Medical instruments and suppliesMarket cap US$9.8BNo P/E

    US$172.68+9.3%1Y

    Since added -1.6%

    B
    성장과 현금
    강하게 성장 중
    Business trend
    둔화
    Business quality
    혼조
    Getting better
    개선 중

    Revenue

    US$805.6M+13.8%

    Profit

    -US$11.8M-779.2%

    Free cash flow

    US$106.7M-3.0%
    Why it is here: Supplies bioprocessing filtration, chromatography and protein products to biologic drug makers
  • BIOBIO-RAD LABORATORIES, INC.

    Medical devicesMarket cap US$10.4BP/E 없음 (영업손실)

    US$386.08+18.0%1Y

    Since added +6.1%

    C
    성장과 현금
    성장 중
    Business trend
    안정
    Business quality
    양호
    Getting better
    개선 중

    Revenue

    US$2.6B+1.4%

    Profit

    US$1B+251.3%

    Free cash flow

    US$329.1M-2.3%
    Why it is here: Sells life science research tools and clinical diagnostics reagents and instruments
  • QGENQIAGEN N.V.

    Diagnostics and researchMarket cap US$10.9BP/E 25.93

    US$50.30+19.8%1Y

    Since added +10.7%

    B+
    성장과 현금
    강하게 성장 중
    Business trend
    안정
    Business quality
    우수
    Getting better
    개선 중

    Revenue

    US$2.1B+2.1%

    Profit

    US$384.5M-5.2%

    Free cash flow

    US$436.2M-8.9%
    Why it is here: Supplies sample preparation and molecular testing kits and instruments
  • GHGUARDANT HEALTH, INC.

    Diagnostics and researchMarket cap US$20.9BP/E 없음 (영업손실)

    US$154.76+58.2%1Y

    Since added -4.5%

    B
    성장과 현금
    강하게 성장 중
    Business trend
    안정
    Business quality
    혼조
    Getting better
    혼조

    Revenue

    US$1.3B+41.7%

    Profit

    -US$485.1M-21.6%

    Free cash flow

    -US$232.1M+11.5%
    Why it is here: Provides blood-based cancer diagnostic tests
  • MEDPMedpace Holdings, Inc.

    Diagnostics and researchMarket cap US$18.6BP/E 36.90

    US$664.52+11.2%1Y

    Since added +9.0%

    C+
    성장과 현금
    강하게 성장 중
    Business trend
    둔화
    Business quality
    우수
    Getting better
    크게 개선 중

    Revenue

    US$2.8B+20.4%

    Profit

    US$517.8M+19.6%

    Free cash flow

    US$667.6M-1.4%
    Why it is here: Runs clinical trials for biotech and pharma drug developers
  • CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC.

    Diagnostics and researchMarket cap US$16.4BP/E 353.20

    US$342.61+99.8%1Y

    Since added +14.5%

    F
    성장과 현금
    혼조
    Business trend
    축소
    Business quality
    혼조
    Getting better
    혼조

    Revenue

    US$4B-1.2%

    Profit

    US$40.2M+148.8%

    Free cash flow

    US$399.6M-26.5%
    Why it is here: Provides preclinical research models and testing services to drug developers

Green and red compare each figure with the same window a year earlier. Grades and checks are the company page's own; nothing here is a recommendation.

DiscussionNo comments yet

Sign in to join the discussion

Be civil and stick to the companies. Comments are opinions, not advice.

    Lists are their owners' own, and notes and comments are opinions. Grades describe businesses from their filings; nothing here is a recommendation to buy or sell.